TuHURA Biosciences (HURA)
Develops immunotherapies aimed at overcoming resistance to cancer treatment.
$2.08
At close+0.05 (+2.46%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
estimated · in 71 days
EPS estimate
−$0.14
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$8.39−$0.15−$0.21−$0.14−$0.13−$0.13−$0.14Pending
Estimate−$0.09−$0.13−$0.14−$0.15−$0.12−$0.13−$0.15−$0.14
Surprise−9,222.2%−15.4%−50.0%+6.7%−1.4%0.0%+8.7%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.14 | — | — |
| Aug 2026 | −$0.15 | −$0.14 | +8.7% |
| May 2026 | −$0.13 | −$0.13 | 0.0% |
| Mar 2026 | −$0.12 | −$0.13 | −1.4% |
| Nov 2025 | −$0.15 | −$0.14 | +6.7% |
The latest year is open to everyone — the 36 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jun 2024 | |||
| May 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.14 | — | — | — | — | — | — |
| Aug 13, 2026 | −$0.15 | −$0.14 | +8.7% | — | — | — | −1.7% |
| May 15, 2026 | −$0.13 | −$0.13 | 0.0% | — | — | — | +10.4% |
| Mar 31, 2026 | −$0.12 | −$0.13 | −1.4% | — | — | — | −9.5% |
| Nov 14, 2025 | −$0.15 | −$0.14 | +6.7% | — | — | — | −8.3% |
The latest year is open to everyone — the 36 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Jun 30, 2024 | |||||||
| May 14, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||